Evaluation of an immunofiltration assay that detects immunoglobulin M antibodies against the ZEBRA protein for the diagnosis of Epstein-Barr virus infectious mononucleosis in immunocompetent patients

Clinical and Vaccine Immunology

Volumn 16, Issue 6, 2009, Pages 885-888

  Bravo, Dayana ^a   Muñoz Cobo, Beatriz ^a   Costa, Elisa ^a   Clari, M Angeles ^a   Tormo, Nuria ^a   Navarro, David ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS ANTIGEN; IMMEDIATE EARLY PROTEIN BZLF1; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; VIRUS ANTIBODY; VIRUS CAPSID ANTIGEN; VIRUS DNA;

ADOLESCENT; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; CHILD; CONTROL GROUP; CONTROLLED STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN HERPESVIRUS 6; HUMAN TISSUE; IMMUNOASSAY; INFECTIOUS MONONUCLEOSIS; MALE; PARVOVIRUS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN M; INFANT; INFECTIOUS MONONUCLEOSIS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TRANS-ACTIVATORS; YOUNG ADULT;

EID: 67249164553     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00123-09     Document Type: Article

References (19)

1. Aalto, S. M., K. Linnavuori, H. Peltola, E. Vuori, B. Weissbrich, J. Shubert, L. Hedman, and K. Hedman. 1998. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J. Med. Virol. 56:186-191.
2. Bauer, C. C., S. W. Aberle, T. Popow-Kraupp, M. Kapitan, H. Hofmann, and E. Puchhammer-Stöckl. 2005. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection. J. Med. Virol. 75:54-58.
3. Binnicker, M. J., D. J. Jespersen, J. A. Harring, L. O. Rollins, and E. M. Beito. 2008. Evaluation of a multiplex flow immunoassay for detection of Epstein-Barr virus-specific antibodies. Clin. Vaccine Immunol. 15:1410-1413.
4. Chan, K. H., M. H. Ng, W. H. Seto, and J. S. M. Peiris. 2001. Epstein-Barr virus (EBV) DNA in sera of patients with primary EBV infection. J. Clin. Microbiol. 39:4152-4154.
5. Countryman, J., and G. Miller. 1985. Activation of expression of latent Epstein-Barr virus after gene transfer of a small subfragment of heterogeneous viral DNA. Proc. Natl. Acad. Sci. USA 82:4085-4089.
6. de Ory, F., J. Antonaya, M. V. Fernández, and J. M. Echevarría. 1993. Application of low-avidity immunoglobulin G studies to diagnosis of Epstein-Barr virus infectious mononucleosis. J. Clin. Microbiol. 31:1669-1671.
7. Gómez, M. C., J. A. Nieto, and M. A. Escribano. 2000. Evaluation of two slide agglutination tests and a novel immunochromatographic assay for rapid diagnosis of infectious mononucleosis. Clin. Diagn. Lab. Immunol. 7:840-841.
8. Gray, J. J. 1995. Avidity of EBV VCA-specific IgG antibodies: distinction between recent primary infection, past infection and reactivation. J. Virol. Methods 52:95-104.
9. Hess, R. D. 2004. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J. Clin. Microbiol. 42:3381-3387.
10. Ijsselmuiden, O. E., G. Beelaert, L. M. Schouls, B. Tank, E. Stolz, and G. van der Groen. 1989. Line immunoassay and enzyme-linked line immunofiltration assay for simultaneous detection of antibody to two treponemal antigens. Eur. J. Clin. Microbiol. Infect. Dis. 8:716-721.
11. Joab, I., J. C. Nicolas, G. Schwabb, G. de Thé, B. Clausse, M. Perricaudet, and Y. Zeng. 1991. Detection of anti-Epstein-Barr virus transactivator (ZEBRA) antibodies in sera from patients with nasopharyngeal carcinoma. Int. J. Cancer 48:647-649.
12. Navalpotro, D., C. Gimeno, and D. Navarro. 2006. Concurrent detection of human herpesvirus type 6 and measles-specific IgMs during acute exanthematic human parvovirus B19 infection. J. Med. Virol. 78:1449-1451.
13. Nystad, T. W., and H. Myrmel. 2007. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM-, and EBNA-1-antibodies and suspected infectious mononucleosis. J. Clin. Virol. 38:292-297.
14. Sumaya, C. V., and Y. Ench. 1985. Epstein-Barr infectious mononucleosis in children. II. Heterophile antibody and viral-specific responses. Pediatrics 75:1011-1019.
15. Tedeschi, R., Y. T. Foong, H. M. Cheng, P. de Paoli, T. Lehtinen, T. Elfborg, and J. Dillner. 1995. The disease associations of the antibody response against the Epstein-Barr virus transactivator protein ZEBRA can be separated into different epitopes. J. Gen. Virol. 76:1393-1400.
16. Thomas, H. I., E. Barret, L. M. Hesketh, A. Wynne, and P. Morgan-Capner. 1999. Simultaneous IgM reactivity by EIA against more than one virus in measles, parvovirus B19 and rubella infection. J. Clin. Virol. 14:107-118.
17. von Lode, P. 2005. Point-of-care immunotesting: approaching the analytical performance of central laboratory methods. Clin. Biochem. 38:591-606.
18. Yamauchi, Y., Y. Tachiband, A. Maeda, H. Wakiguchi, M. Usui, T. Kurata, and T. Sairenji. 1998. Evaluation of antibodies to the Epstein-Barr immediate early gene product ZEBRA by a new enzyme-linked immunosorbent assay. Intervirology 41:278-284. (Pubitemid 29229627)
19. Zufferey, J., P. Hohlfeld, J. Bille, C. L. Fawer, D. Blanc, J. M. Pinon, and B. Vaudaux. 1999. Value of the comparative enzyme-linked immunofiltration assay for early neonatal diagnosis of congenital Toxoplasma infection. Pediatr. Infect. Dis. J. 18:971-975.